G

Galecto
D

GLTO

4.64000
USD
0.05
(1.09%)
Market Closed
Volume
15
EPS
-16
Div Yield
-
P/E
-0
Market Cap
6,110,829
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMA
    -0.238
    (-1.48%)
    15.835 USD
    A
    ARDX
    -0.65000
    (-11.39%)
    5.05500 USD
    B
    BPMC
    -2.080
    (-2.20%)
    92.280 USD
    C
    CKPT
    -0.05000
    (-1.57%)
    3.13000 USD
    KHC
    KHC
    0.985
    (3.27%)
    31.140 USD
    K
    KOD
    -0.29500
    (-6.23%)
    4.44000 USD
    M
    MGNX
    -0.13000
    (-4.50%)
    2.76000 USD
    N
    NVCR
    0.420
    (1.94%)
    22.090 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    More
News

Title: Galecto Inc

Sector: Healthcare
Industry: Biotechnology
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.